| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 42 | 48 | 48 | 52 | 57 | 58 | 70 | 59 | 77 | 77 | 76 | 79 |
| Expenses | 35 | 41 | 41 | 48 | 50 | 51 | 59 | 51 | 67 | 67 | 68 | 69 |
| EBITDA | 7 | 7 | 7 | 5 | 7 | 7 | 11 | 8 | 10 | 10 | 8 | 10 |
| Operating Profit % | 14 % | 14 % | 14 % | 9 % | 10 % | 11 % | 14 % | 12 % | 11 % | 12 % | 9 % | 11 % |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 |
| Profit Before Tax | 5 | 5 | 5 | 3 | 4 | 4 | 8 | 5 | 7 | 7 | 5 | 7 |
| Tax | 1 | 1 | 2 | 0 | 1 | 1 | 3 | 2 | 2 | 1 | 2 | 2 |
| Net Profit | 3 | 4 | 3 | 2 | 3 | 3 | 5 | 4 | 6 | 6 | 3 | 5 |
| EPS in ₹ | 27.61 | 32.69 | 22.53 | 16.78 | 23.63 | 26.90 | 44.48 | 29.68 | 46.49 | 47.12 | 26.21 | 40.90 |
Mercury Laboratories
Mercury Laboratories
873.00
-873.00
(-100.00%)
Q1 Quarterly Results are out. Check out the updated financials1 day ago
View
Key Fundamentals
Market Cap
104.80 Cr
EPS
26.21
PE Ratio
21.32
Dividend Yield
0.40 %
Industry
Healthcare 52 Week High
1,005.00
52 Week Low
736.00
PB Ratio
1.88
Debt to Equity
0.11
Sector
Pharmaceuticals Actual
Company News
View All News
Mercury Laboratories Assigns Additional VP Role to Chief Operating Officer3 days ago
Mercury Laboratories Limited has assigned an additional role of Vice President-Marketing Sales to Saurabh Mittal, who serves as Chief Operating Officer, effective November 17, 2025. The appointment involves a senior management personnel with over 15 years of corporate experience in marketing, business development, and system processes across established and start-up organizations.
Mercury Laboratories Delays New Injectable Plant Commissioning by 13 Months to December 2026
9 days ago
9 days agoMercury Laboratories has deferred the commissioning of its new Small Volume Parenteral (SVPs) manufacturing plant by 13 months from the originally scheduled November 2025 to December 2026. The plant, located at Jarod with a capacity to manufacture 75 million units annually, involves an estimated cost of INR 30 crores. The delay is attributed to revisions in Schedule M guidelines by the Ministry of Health and Family Welfare, which mandated additional compliance and infrastructural requirements for pharmaceutical manufacturing facilities. The company states there is no material adverse impact on overall business operations due to the delay and is taking necessary steps to expedite project completion.
Mercury Laboratories Limited announced its unaudited financial results for the quarter and half year ended September 30, 2025. The pharmaceutical company reported a net profit after tax of Rs 164.33 lakhs for the quarter, compared to Rs 96.76 lakhs in the previous quarter, representing a significant increase. Revenue from operations for the quarter stood at Rs 1,900.86 lakhs, up from Rs 1,813.54 lakhs in the previous quarter. For the half year period, net profit reached Rs 261.09 lakhs with revenue from operations at Rs 3,714.40 lakhs. The company's total comprehensive income for the quarter was Rs 164.00 lakhs. Basic earnings per share for the quarter was Rs 13.69 compared to Rs 8.06 in the previous quarter. The Board of Directors approved these results at their meeting held on November 11, 2025. The company operates in a single segment of pharmaceutical products and has paid-up equity share capital of Rs 120.00 lakhs with face value of Rs 10 per share.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,783.00 | #1 4,27,801.43 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 71.49 | |
6,393.00 | 1,69,714.06 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 47.34 | |
3,690.80 | 1,24,913.44 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 54.89 | |
1,517.80 | 1,22,600.91 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 48.01 | |
1,248.30 | 1,04,184.84 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 53.56 | |
926.25 | 93,202.42 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.23 | |
2,032.30 | 92,826.22 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 58.77 | |
2,241.00 | 92,499.18 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 32.96 | |
1,211.00 | 70,335.08 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 63.26 | |
5,697.00 | 68,116.18 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 60.35 |
Growth Rate
Revenue Growth
-0.52 %
Net Income Growth
-45.61 %
Cash Flow Change
-51.40 %
ROE
-47.21 %
ROCE
-33.26 %
EBITDA Margin (Avg.)
-19.62 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 43 | 47 | 51 | 52 | 57 | 56 | 65 | 62 | 64 | 68 | 74 |
| Fixed Assets | 20 | 19 | 18 | 21 | 24 | 24 | 26 | 26 | 24 | 24 | 25 |
| Current Assets | 23 | 28 | 32 | 30 | 32 | 32 | 38 | 35 | 40 | 40 | 40 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 9 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 23 | 28 | 32 | 31 | 33 | 33 | 39 | 37 | 40 | 40 | 40 |
| Total Liabilities | 43 | 47 | 51 | 52 | 57 | 56 | 65 | 62 | 64 | 68 | 74 |
| Current Liabilities | 21 | 21 | 17 | 13 | 17 | 15 | 19 | 16 | 14 | 13 | 15 |
| Non Current Liabilities | 4 | 4 | 10 | 12 | 11 | 9 | 10 | 6 | 4 | 5 | 6 |
| Total Equity | 18 | 22 | 25 | 26 | 29 | 32 | 37 | 40 | 46 | 51 | 54 |
| Reserve & Surplus | 17 | 21 | 23 | 25 | 28 | 31 | 36 | 39 | 44 | 50 | 52 |
| Share Capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | 0 | 2 | -2 | 1 | 2 | 2 | 0 | 1 | -6 |
| Investing Activities | -2 | -0 | -2 | -4 | -5 | -1 | -5 | -2 | -1 | -6 | -9 |
| Operating Activities | 4 | -0 | 2 | 5 | 5 | 6 | 8 | 5 | 3 | 8 | 4 |
| Financing Activities | -2 | 1 | -0 | 1 | -3 | -3 | -1 | -1 | -1 | -1 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % | 73.66 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 17.25 % | 17.21 % | 17.23 % | 17.11 % | 17.17 % | 17.09 % | 17.07 % | 16.76 % | 16.83 % | 16.85 % | 16.79 % | 16.77 % | 16.86 % | 16.86 % | 16.79 % | 16.63 % | 16.66 % | 16.66 % | 16.71 % |
| Others | 9.09 % | 9.13 % | 9.11 % | 9.23 % | 9.17 % | 9.25 % | 9.28 % | 9.58 % | 9.52 % | 9.49 % | 9.55 % | 9.57 % | 9.48 % | 9.48 % | 9.55 % | 9.71 % | 9.68 % | 9.68 % | 9.63 % |
| No of Share Holders | 0 | 948 | 1,108 | 1,139 | 1,112 | 1,175 | 1,182 | 1,185 | 1,146 | 1,119 | 1,149 | 1,161 | 1,214 | 1,259 | 1,345 | 1,411 | 1,397 | 1,384 | 1,365 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1.5 | 1.5 | 1.5 | 2 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 |
| Dividend Yield (%) | 0.00 | 0.38 | 0.44 | 0.53 | 0.31 | 0.72 | 0.63 | 0.42 | 0.43 | 0.4 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Feb 2021 |  Dividend | ₹ 1.50 /share | 22 Feb 2021 | 668.25 | 694.95 |
| 22 Sept 2021 | Dividend | ₹ 2.00 /share | 20 Sept 2021 | 804.55 | 720.00 |
| 21 Sept 2022 | Dividend | ₹ 3.50 /share | 19 Sept 2022 | 475.00 | 590.00 |
| 21 Sept 2023 | Dividend | ₹ 3.50 /share | 20 Sept 2023 | 627.50 | 790.00 |
| 21 Sept 2024 | Dividend | ₹ 3.50 /share | 20 Sept 2024 | 865.00 | 1,033.75 |
| 27 Sept 2024 |  Annual General Meeting | NA | 27 Sept 2024 | 1,021.00 | 1,005.75 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 988.75 | 940.45 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 867.00 | 829.00 |
| 14 May 2025 | Quarterly Result Announcement | NA | 14 May 2025 | 893.40 | 877.80 |
| 06 Aug 2025 | Dividend | ₹ 3.50 /share | 06 Aug 2025 | 877.80 | 869.90 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 893.55 | 835.95 |
| 13 Aug 2025 | Annual General Meeting | NA | 13 Aug 2025 | 877.80 | 835.95 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 840.00 | 860.00 |
Announcements
Announcement under Regulation 30 (LODR)-Change in Management3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication8 days ago
8 days agoUpdates On New Small Volume Parenteral (Svps) Plant At Jarod9 days ago
9 days agoUnaudited Financial Results For The Quarter And Half Year Ended On September 20259 days ago
9 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On November 11 20259 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Change in ManagementNov 07, 2025
Nov 07, 2025Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025 Scheduled To Be Held On November 11 2025Nov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 04, 2025
Nov 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 06, 2025
Oct 06, 2025Communication To Shareholders Regarding 100 Days Campaign - Saksham NiveshakOct 04, 2025
Oct 04, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 13, 2025
Aug 13, 2025Unaudited Financial Results For The Quarter Ended On June 30 2025Aug 13, 2025
Aug 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On August 13 2025Aug 13, 2025
Aug 13, 2025Board Meeting Intimation for To Consider And Approve Of Unaudited Financial Results For The Quarter Ended On June 30 2025Aug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 19, 2025
Jul 19, 2025Notice Of 44Th AGM Of The Company To Be Held On August 13 2025Jul 17, 2025
Jul 17, 2025Reg. 34 (1) Annual Report.Jul 17, 2025
Jul 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2025
Jul 11, 2025Shareholder Communication For Tax Deduction On Dividend For The Financial Year 2024-25 And Updation Of Various DetailsJul 10, 2025
Jul 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Announcement under Regulation 30 (LODR)-Credit RatingJul 02, 2025
Jul 02, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
May 21, 2025Intimation To Shareholders Relating To Transfer Of Equity Shares To IEPF AuthorityMay 20, 2025
May 20, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 17, 2025
May 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Book Closure & Record Date - Pursuant To Regulation 42 & 30 Of The SEBI (LODR) Regulations 2015May 14, 2025
May 14, 2025Intimation For Appointment Of An Internal Auditors Secretarial Auditors & Cost AuditorsMay 14, 2025
May 14, 2025Intimation Of Book ClosureMay 14, 2025
May 14, 2025Intimation Of Book ClosureMay 14, 2025
May 14, 2025Corporate Action-Board approves DividendMay 14, 2025
May 14, 2025Results For The Financial Year Ended On March 31 2025May 14, 2025
May 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On May 14 2025May 14, 2025
May 14, 2025Revised Board Meeting Intimation For Approval Of Audited Financial Results For The Quarter And Financial Year Ended On 31St March 2025 And To Recommend Dividend If Any And To Consider Other Items Of AgendaMay 08, 2025
May 08, 2025Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended On 31St March 2025 And To Recommend Dividend If Any And To Consider Other Items Of AgendaMay 08, 2025
May 08, 2025Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 29, 2025
Apr 29, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 16, 2025
Apr 16, 2025Disclosure Under Regulation 30 Of The SEBI (LODR) Reg 2015- Imposition Of PenaltyApr 16, 2025
Apr 16, 2025Change In Email Address Of RTA MUFG Intime India Pvt LtdApr 11, 2025
Apr 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 05, 2025
Apr 05, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2025
Feb 14, 2025Integrated Filing (Financial)Feb 12, 2025
Feb 12, 2025Results-Financial Results For Quarter And Nine Months Ended On December 31 2024Feb 12, 2025
Feb 12, 2025Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2024Feb 12, 2025
Feb 12, 2025Technical Indicators
RSI(14)
Neutral 52.02
ATR(14)
Less Volatile 35.61
STOCH(9,6)
Neutral 43.37
STOCH RSI(14)
Neutral 30.50
MACD(12,26)
Bearish -0.80
ADX(14)
Weak Trend 11.06
UO(9)
Bearish 43.28
ROC(12)
Uptrend And Accelerating 1.02
WillR(14)
Neutral -49.34
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
